PHARMACEUTICALS

Our portfolio builds upon 40 years of safety data with FDA approved medicines. Our new molecules and prodrugs can deliver cannabinoids only where they are needed, avoiding unwanted side effects like psychoactivity that have limited their use in pediatrics and sensitive populations. Placer Biosciences maintains a DEA research permit and is in full compliance with federal laws that govern the research of controlled substances.